Medtronic, Nile Therapeutics to work on drug-device combo

02/28/2011 | American City Business Journals

Medtronic has agreed to partner with Nile Therapeutics to develop a peptide drug, called cenderitide, for heart failure and renal disease that can be delivered by its diabetes pump system. Under the agreement, Nile will focus on conducting a first-stage trial of the peptide, and Medtronic will provide financing and share its knowledge in developing drug-device combination products.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC